Bumrungrad Hospital (BH) Q2 2026 (Q&A) earnings summary

Executive summary

• Revenue for the three months ended 30 June 2026 was THB 6,278 million, up from THB 6,104 million year-over-year.

• Net profit for the quarter was THB 1,910 million, compared to THB 1,880 million in the prior year.

• For the six-month period, revenue reached THB 12,532 million and net profit was THB 3,710 million, both showing year-over-year growth.

Financial highlights

• Operating profit for Q2 2026 was THB 2,308 million, up from THB 2,279 million year-over-year.

• Basic EPS for Q2 2026 was THB 2.38, up from THB 2.34; for six months, basic EPS was THB 4.63, up from THB 4.52.

• Cash and cash equivalents decreased to THB 3,907 million as of 30 June 2026 from THB 7,595 million at year-end 2025.

• Total assets stood at THB 33,160 million, with total equity of THB 27,713 million as of 30 June 2026.

Outlook and guidance

• An interim dividend of THB 4 per share (THB 3,183 million total) was approved post-period, to be paid in September 2026.

• Management is evaluating the impact of new accounting standards effective in 2028.